Saizen + Saizen
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Growth Hormone Deficiency
Conditions
Growth Hormone Deficiency, Turner Syndrome
Trial Timeline
May 31, 2005 → Sep 30, 2007
NCT ID
NCT00256126About Saizen + Saizen
Saizen + Saizen is a approved stage product being developed by Merck for Growth Hormone Deficiency. The current trial status is completed. This product is registered under clinical trial identifier NCT00256126. Target conditions include Growth Hormone Deficiency, Turner Syndrome.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00256126 | Approved | Completed |
Competing Products
20 competing products in Growth Hormone Deficiency